U.S. medical eligibility criteria for contraceptive use, 2016

MMWR Recommendations and Reports

Volumn 65, Issue 3, 2016, Pages 1-104

  Curtis, Kathryn M ^a   Tepper, Naomi K ^a   Jatlaoui, Tara C ^a   Berry Bibee, Erin ^a,b   Horton, Leah G ^a   Zapata, Lauren B ^a   Simmons, Katharine B ^a,b   Pagano, H Pamela ^a   Jamieson, Denise J ^a   Whiteman, Maura K ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT;

CONTRACEPTION; CONTRAINDICATIONS; FAMILY PLANNING; FEMALE; HEALTH CARE DELIVERY; HUMAN; MALE; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PREGNANCY; PROCEDURES; RISK ASSESSMENT; UNITED STATES; UNPLANNED PREGNANCY;

CONTRACEPTION; CONTRACEPTIVE AGENTS; ELIGIBILITY DETERMINATION; FAMILY PLANNING SERVICES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY, UNPLANNED; RISK ASSESSMENT; UNITED STATES;

EID: 84983486809     PISSN: 10575987     EISSN: 15458601     Source Type: Journal    
DOI: 10.15585/mmwr.rr6503a1     Document Type: Article

References (12)

1. Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008-2011. N Engl J Med 2016;374:843-52.http://dx.doi. org/10.1056/NEJMsa1506575
2. Gipson JD, Koenig MA, Hindin MJ. The effects of unintended pregnancy on infant, child, and parental health: a review of the literature. Stud Fam Plann 2008;39:18-38. http://dx.doi.org/10.1111/j.1728-4465.2008.00148.x
3. Sonfield A, Kost K. Public costs from unintended pregnancies and the role of public insurance programs in paying for pregnancy-related care: national and state estimates for 2010. New York: Guttmacher Institute; 2015.
4. World Health Organization. Medical eligibility criteria for contraceptive use. 4th ed. Geneva, Switzerland: World Health Organization; 2009.
5. CDC. U.S. medical eligibility criteria for contraceptive use, 2010. MMWR Recomm Rep 2010;59(No. RR-4).
6. Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. selected practice recommendations for contraceptive use, 2016. MMWR Recomm Rep 2016;65(No. RR-4).
7. Mohllajee AP, Curtis KM, Flanagan RG, Rinehart W, Gaffield ML, Peterson HB. Keeping up with evidence a new system for WHO's evidence-based family planning guidance. Am J Prev Med 2005;28:483-90.http://dx.doi.org/10.1016/j.amepre.2005.02.008
8. Liberati A, Altman DG, TetzlaffJ, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62:e1-34. http://dx.doi.org/10.1016/j.jclinepi.2009.06.006
9. Moher D, Liberati A, TetzlaffJ, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010;8:336-41. http://dx.doi.org/10.1016/j. ijsu.2010.02.007
10. Harris RP, Helfand M, Woolf SH, et al; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001;20(Suppl):21-35. http://dx.doi.org/10.1016/S0749-3797(01)00261-6
11. Horton L, Folger SG, Berry-Bibee E, Jatlaoui TC, Tepper NK, Curtis KM. Research gaps from evidence-based contraception guidance: the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016, and the U.S. Selected Practice Recommendations for Contraceptive Use, 2016. Contraception. In press 2016.
12. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015;64(No. RR-3).